# Peter Stacpoole, M.D. – FDA Inspection, Jun 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/peter-stacpoole-md/ce27bc64-25b1-44ca-a3d8-9d4e3981358d
Source feed: FDA_Inspections

> FDA inspection 1014219 of Peter Stacpoole, M.D., June 15, 2017. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014219
- Company Name: Peter Stacpoole, M.D.
- Inspection Date: 2017-06-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 7

## Related Officers

- [Company Rep](https://www.keypedia.com/people/traci-m-armand/3af556f9-942c-4e58-85ee-f7d261a236ce)

Company: https://www.keypedia.com/companies/peter-stacpoole-md/259c1b5d-fe47-4486-81a9-310e570ea52b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c